Amylases, antagonists & inhibitors
DBCAT005122Pharmacologic class
A DrugBank category of 1 drug. 1 of them is approved.
- Drugs
What you can answer from here — as of February 05, 2020
Which targets do Amylases, antagonists & inhibitors share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account